1. Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation;Abraham,1995
2. Science, politics, and health in the brave new world of pharmaceutical carcinogenic risk assessment: Technical progress or cycle of regulatory capture?;Abraham;Social Science & Medicine,2012
3. E-government implementation: Transparency, accessibility and usability of government websites;Alcaraz-Quiles,2017
4. EPA’s proposed transparency rule: Factors to consider, many; planets to live on, one;Allison;Proceedings of the National Academy of Sciences,2020
5. The causes of fiscal transparency: Evidence from the U.S. States;Alt;IMF Staff Papers,2006